Live Breaking News & Updates on Deepali Kuma

Stay updated with breaking news from Deepali kuma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Canadian-made COVID-19 antibody treatment sitting on shelves due to lack of administration plan


 
TORONTO
A Canadian-made COVID-19 antibody treatment is sitting on hospital and pharmacy shelves amid the country’s third wave of the pandemic because doctors say a plan on how to administer the drug was never made.
“It s actually very frustrating that we have a therapy available to us that we re not actually able to use,” said infectious disease expert Dr. Deepali Kuma.
Bamlanivimab is a monoclonal antibody directed against the spike protein of SARS-CoV-2, the virus that causes COVID-19. The drug mimics the immune system s ability to fight off the virus and was developed by AbCellera Biologics Inc. in Vancouver with the support of the federal government, which had committed up to $175.6 million to the company in May 2020 to develop antibody therapies. ....

United States , United Kingdom , British Columbia , John Tavel , Donald Trump , Matthew Miller , Deepali Kuma , Abcellera Biologics , Carl Hansen , Biomedical Sciences At Mcmaster University , Abcellera Biologics Inc , Eli Lilly Canada Inc , National News , Health Canada , Department Of Biochemistry , Eli Lilly Canada , Biomedical Sciences , Mcmaster University , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , டொனால்ட் துருப்பு , மேத்யூ மில்லர் , கார்ல் ஹேன்சன் , உயிர் மருத்துவ அறிவியல் இல் மக்மாஸ்டர் பல்கலைக்கழகம் , எலி லில்லி கனடா இன்க் ,